TrialNature communications2026

Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives.

Alexander G Raufi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.